Amino acid catabolism: transamination, the urea cycle, and amino acid biosynthesis overview

Intuition Beginner

Proteins are constantly being broken down and rebuilt in your body. When a protein is no longer needed, or when you are starving and need fuel, its amino acids can be harvested for energy. But amino acids carry a nitrogen-containing amino group that cannot enter the standard energy-producing pathways. The cell must first strip off that amino group and safely dispose of it.

The removal happens through transamination: an enzyme transfers the amino group from the amino acid to a molecule called alpha-ketoglutarate, producing glutamate. This is a swap, not a destruction — the nitrogen moves to a new carrier rather than being released as free ammonia, which is toxic.

The liver then converts the nitrogen from glutamate into urea, a much less toxic compound, through the urea cycle. Urea dissolves in blood, travels to the kidneys, and is excreted in urine. Meanwhile, the remaining carbon skeleton of the original amino acid — now stripped of its nitrogen — feeds into familiar energy pathways like the citric acid cycle.

Visual Beginner

The diagram above shows an amino acid losing its amino group via transamination, the amino group being converted to urea in the liver through the urea cycle, and the remaining carbon skeleton entering central metabolic pathways such as the citric acid cycle.

Worked example Beginner

What happens to the amino acid alanine when it is used for energy?

Alanine is a simple amino acid whose carbon skeleton is pyruvate. The first step is transamination: the enzyme alanine aminotransferase (ALT) transfers alanine's amino group to alpha-ketoglutarate, producing glutamate and pyruvate.

The glutamate carries the amino group to the liver's mitochondria, where glutamate dehydrogenase removes the amino group as free ammonia (NH₄⁺). That ammonia enters the urea cycle and is eventually excreted as urea.

The pyruvate has no nitrogen left, so it enters mainstream energy metabolism. It can be converted to acetyl-CoA and oxidized in the citric acid cycle, or it can be used to build glucose through gluconeogenesis. This is why alanine is classified as a glucogenic amino acid — its carbon skeleton can be converted to glucose.

Check your understanding Beginner

Formal definition Intermediate+

Amino acid catabolism proceeds in three stages: (1) removal of the amino group, (2) disposal of the nitrogen as urea, and (3) breakdown of the carbon skeleton into intermediates of central metabolism.

Transamination

Aminotransferases (also called transaminases) catalyze the transfer of an amino group from an amino acid to an alpha-keto acid, typically alpha-ketoglutarate. The reaction uses pyridoxal phosphate (PLP), the active form of vitamin B6, as a cofactor. PLP forms a Schiff base (aldimine) with the amino acid substrate, and the reaction proceeds through a ping-pong Bi-Bi mechanism: the amino acid donates its group to the enzyme-PLP complex, forming pyridoxamine phosphate (PMP) and releasing the corresponding alpha-keto acid; then PMP donates the amino group to a second alpha-keto acid substrate, regenerating PLP.

Two clinically important aminotransferases are:

• Alanine aminotransferase (ALT): alanine + alpha-ketoglutarate ⇌ pyruvate + glutamate
• Aspartate aminotransferase (AST): aspartate + alpha-ketoglutarate ⇌ oxaloacetate + glutamate

Elevated ALT and AST in blood serum are markers of liver damage, because these intracellular enzymes leak from damaged hepatocytes.

Glutamate dehydrogenase

Glutamate dehydrogenase (GDH) occupies a unique position: it catalyzes the oxidative deamination of glutamate to alpha-ketoglutarate and free ammonia (NH₄⁺), using NAD⁺ (or NADP⁺) as the electron acceptor. GDH links transamination to the urea cycle, because the ammonia it produces feeds directly into carbamoyl phosphate synthesis. GDH is allosterically activated by ADP (signaling low energy) and inhibited by GTP (signaling high energy).

The urea cycle

The urea cycle converts toxic ammonia to urea in five enzymatic steps, the first two occurring in the mitochondrial matrix and the remaining three in the cytosol:

1. Carbamoyl phosphate synthetase I (CPS1): NH₄⁺ + HCO₃⁻ + 2 ATP → carbamoyl phosphate + 2 ADP + Pᵢ. This is the committed step and consumes two ATP equivalents.
2. Ornithine transcarbamylase (OTC): carbamoyl phosphate + ornithine → citrulline + Pᵢ. Citrulline is transported to the cytosol.
3. Argininosuccinate synthetase (ASS): citrulline + aspartate + ATP → argininosuccinate + AMP + PPᵢ. This consumes one ATP (cleaved to AMP, so two high-energy bonds).
4. Argininosuccinate lyase (ASL): argininosuccinate → arginine + fumarate. Fumarate can re-enter the citric acid cycle or be converted back to aspartate.
5. Arginase: arginine + H₂O → urea + ornithine. Ornithine re-enters the mitochondrion to continue the cycle.

The overall stoichiometry of the urea cycle is: NH₄⁺ + HCO₃⁻ + aspartate + 3 ATP → urea + fumarate + 2 ADP + AMP + 2 Pᵢ + PPᵢ. Four high-energy phosphate bonds are consumed per urea molecule synthesized.

Glucogenic and ketogenic amino acids

Amino acids are classified by the entry point of their carbon skeletons into central metabolism:

• Glucogenic amino acids are degraded to pyruvate, alpha-ketoglutarate, succinyl-CoA, or oxaloacetate — all of which can serve as precursors for glucose synthesis via gluconeogenesis. Examples: alanine → pyruvate; glutamate → alpha-ketoglutarate; aspartate → oxaloacetate.
• Ketogenic amino acids are degraded to acetyl-CoA or acetoacetyl-CoA, which cannot be converted to glucose in animals. Leucine and lysine are purely ketogenic.
• Some amino acids are both glucogenic and ketogenic: isoleucine, phenylalanine, tyrosine, tryptophan, and threonine yield both types of intermediates.

Essential and nonessential amino acids

Humans can synthesize approximately half of the 20 standard amino acids from central metabolic intermediates. The essential amino acids — those that must be obtained from the diet — are: histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine. Nonessential amino acids are synthesized through relatively short pathways: alanine from pyruvate (one transamination), aspartate from oxaloacetate (one transamination), glutamate from alpha-ketoglutarate (one reductive amination), and so on.

Nitrogen balance

Nitrogen balance is the difference between nitrogen intake (dietary protein) and nitrogen excretion (urea, NH₄⁺, creatinine). A healthy adult in steady state is in nitrogen equilibrium (zero balance). Positive nitrogen balance (intake exceeds excretion) occurs during growth, pregnancy, and recovery from illness. Negative nitrogen balance (excretion exceeds intake) occurs during starvation, severe illness, or inadequate dietary protein.

Key mechanism Intermediate+

Stoichiometry of the urea cycle and nitrogen economy

For each turn of the urea cycle, one molecule of urea (containing two nitrogen atoms) is produced. One nitrogen atom originates from free ammonia (via CPS1) and the second from the amino group of aspartate (via ASS). The aspartate nitrogen is itself derived from transamination of oxaloacetate by AST, meaning the urea cycle integrates nitrogen from two sources.

The energy cost is four high-energy phosphate bonds per urea molecule: two ATP hydrolyzed to ADP + Pᵢ by CPS1, one ATP hydrolyzed to AMP + PPᵢ by ASS (equivalent to two high-energy bonds), yielding a total of four. Urea contains two nitrogen atoms, so the energy cost is approximately 2.5 ATP per nitrogen atom when accounting for the regeneration of fumarate to oxaloacetate and then to aspartate through partial citric acid cycle reactions.

The fumarate produced by ASL is a connecting point between the urea cycle and the citric acid cycle (sometimes called the Krebs bicycle). Fumarate can be converted to malate and then oxaloacetate in the cytosol; oxaloacetate is then transaminated to regenerate aspartate, completing the link.

Amino acid catabolism disorders and nitrogen disposal in tissues Master

Urea cycle disorders

Deficiencies in each of the five urea cycle enzymes (and the transporter ORNT1) produce distinct clinical syndromes united by hyperammonemia — elevated blood ammonia. Ammonia crosses the blood-brain barrier and causes cerebral edema, lethargy, seizures, coma, and death if untreated.

OTC deficiency is the most common urea cycle disorder (X-linked). Males with severe neonatal-onset disease present within the first days of life with progressive lethargy, vomiting, and seizures. Laboratory findings show elevated plasma ammonia, elevated glutamine, low citrulline, and elevated orotic acid (carbamoyl phosphate that cannot enter the urea cycle is shunted into pyrimidine synthesis). Treatment involves nitrogen scavengers (sodium phenylbutyrate, sodium benzoate), dietary protein restriction, and in severe cases, liver transplantation.

CPS1 deficiency presents similarly to OTC deficiency but orotic acid is low or normal, because carbamoyl phosphate is not being produced and therefore not shunted to pyrimidine synthesis. This biochemical distinction is diagnostically critical.

Tissue-specific nitrogen disposal

Different tissues handle amino acid nitrogen through distinct shuttle mechanisms:

• The glucose-alanine cycle (muscle): During exercise or fasting, skeletal muscle breaks down protein and transaminates the resulting amino acids to produce alanine (via ALT). Alanine is released into the blood, taken up by the liver, and its amino group is removed for urea synthesis while its carbon skeleton (pyruvate) is used for gluconeogenesis. The resulting glucose is exported back to muscle. This cycle transports nitrogen from muscle to liver in a nontoxic form.
• The glutamine shuttle (brain, intestine, immune cells): Neurons and rapidly dividing cells release amino groups as glutamine rather than alanine. Glutamine synthetase in astrocytes condenses glutamate with ammonia in an ATP-dependent reaction, producing glutamine. Glutamine is transported to the liver or kidneys, where glutaminase hydrolyzes it back to glutamate and ammonia. In the kidney, this ammonia is directly excreted into the urine, serving as a buffer for acid-base homeostasis.
• The purine nucleotide cycle (muscle): An alternative nitrogen-disposal route in skeletal muscle involves AMP deaminase converting AMP to IMP with release of NH₃, followed by adenylosuccinate synthetase using aspartate to regenerate AMP. This cycle also generates fumarate, feeding the citric acid cycle.

Branched-chain amino acid catabolism

The three branched-chain amino acids (BCAAs) — leucine, isoleucine, and valine — are unique because their catabolism begins outside the liver. Branched-chain aminotransferase (BCAT) is highly expressed in skeletal muscle and brain, performing the initial transamination to produce the corresponding branched-chain alpha-keto acids (BCKAs). The second step, branched-chain alpha-keto acid dehydrogenase (BCKDH), is a multi-enzyme complex analogous to pyruvate dehydrogenase, located in mitochondria. BCKDH is regulated by phosphorylation (inactivation) and dephosphorylation (activation), with the kinase being inhibited by BCKAs.

Maple syrup urine disease (MSUD) results from deficiency in BCKDH. BCKAs and their derivatives accumulate, producing a characteristic sweet odor in urine and cerumen. If untreated, the condition causes severe neurological damage and death in the neonatal period. Management requires a diet restricted in BCAAs and, in some forms, thiamine supplementation (thiamine is a cofactor for BCKDH).

Phenylalanine catabolism and PKU

Phenylalanine is converted to tyrosine by phenylalanine hydroxylase (PAH), which uses tetrahydrobiopterin (BH₄) as a cofactor. Phenylketonuria (PKU), caused by PAH deficiency, is the most common inborn error of amino acid metabolism (incidence approximately 1 in 10,000). Phenylalanine accumulates and is transaminated to phenylpyruvate, which is excreted in urine. If untreated, elevated phenylalanine impairs brain development, causing intellectual disability, seizures, and behavioral disorders. Newborn screening programs detect PKU before symptoms develop, and dietary phenylalanine restriction from infancy prevents neurological damage.

BH₄ deficiency (malignant PKU) produces a more severe phenotype because BH₄ is also required for tyrosine hydroxylase and tryptophan hydroxylase, the rate-limiting enzymes for dopamine and serotonin synthesis. These patients require BH₄ supplementation in addition to dietary management.

Homocystinuria and one-carbon metabolism

Methionine is adenylated to S-adenosylmethionine (SAM), the primary methyl donor in the cell. After methyl transfer, SAM becomes S-adenosylhomocysteine (SAH), which is hydrolyzed to homocysteine. Homocysteine can be remethylated to methionine (by methionine synthase, using methyl-THF and vitamin B₁₂) or condensed with serine by cystathionine beta-synthase (CBS) to form cystathionine, which is then cleaved to cysteine.

Classical homocystinuria results from CBS deficiency. Homocysteine accumulates, causing lens dislocation, skeletal abnormalities (marfanoid habitus), thromboembolism, and intellectual disability. Elevated plasma homocysteine is also an independent risk factor for cardiovascular disease in the general population.

One-carbon metabolism encompasses the network of reactions involving folate derivatives that transfer single-carbon units (methyl, methylene, methenyl, formyl, formimino groups). These reactions are essential for nucleotide synthesis, amino acid interconversion, and epigenetic regulation via SAM-dependent methylation of DNA and histones. Tetrahydrofolate (THF) serves as the one-carbon carrier, and its interconversion with methyl-THF links one-carbon metabolism to the homocysteine-methionine cycle.

Exercises Intermediate+

Connections Master

Amino acid catabolism intersects with nearly every branch of metabolism:

1. The citric acid cycle is the central hub for carbon skeleton disposal. Glutamate feeds in at alpha-ketoglutarate, aspartate at oxaloacetate, and several amino acids at succinyl-CoA (methionine, valine, isoleucine, threonine). The fumarate produced by the urea cycle re-enters the citric acid cycle, coupling nitrogen excretion to energy metabolism through the Krebs bicycle.

2. Gluconeogenesis depends heavily on glucogenic amino acids during fasting. Alanine from muscle and glutamine from various tissues are the major gluconeogenic precursors when glycogen stores are depleted. The Cori cycle and glucose-alanine cycle are complementary strategies for recycling carbon and disposing of nitrogen during catabolic states.

3. Fatty acid metabolism receives carbon from ketogenic amino acids. Leucine and lysine produce acetyl-CoA or acetoacetyl-CoA, feeding ketogenesis during fasting. The shared use of acetyl-CoA as an intermediate means amino acid catabolism and fat metabolism converge at the same metabolic node.

4. Nucleotide biosynthesis requires several amino acids as precursors: glycine, aspartate, and glutamine are direct building blocks of purine and pyrimidine rings. The urea cycle by-product carbamoyl phosphate (when produced by CPS2 in the cytosol) feeds directly into pyrimidine synthesis. Orotic aciduria in OTC deficiency illustrates what happens when mitochondrial carbamoyl phosphate overflows into the pyrimidine pathway.

5. One-carbon metabolism and epigenetics: SAM-dependent methylation of DNA and histones depends on adequate methionine and folate metabolism. Disruption of one-carbon metabolism alters epigenetic marks, with implications for cancer, neural tube defects, and cardiovascular disease.

6. Hormone synthesis: Tyrosine is the precursor for catecholamines (dopamine, norepinephrine, epinephrine) and thyroid hormones (T3, T4). Tryptophan is the precursor for serotonin and melatonin. Histidine decarboxylation yields histamine. These pathways link amino acid metabolism directly to neurotransmission, endocrine signaling, and immune function.

7. Oxidative phosphorylation receives reducing equivalents (NADH, FADH2) from amino acid carbon skeleton oxidation. Conversely, several amino acid biosynthetic pathways require NADPH, linking amino acid metabolism to the pentose phosphate pathway.

Historical notes Master

Hans Krebs and Kurt Henseleit discovered the urea cycle in 1932, before Krebs elucidated the citric acid cycle. Working with liver slices, they observed that urea synthesis was stimulated by the addition of ornithine, citrulline, or arginine, and they proposed a cyclic pathway in which ornithine was regenerated after each turn. This was the first metabolic cycle ever described and established the concept of cyclic biochemical pathways.

The role of transamination was established by Alexander Braunstein and Maria Kritzmann in 1937, who demonstrated that amino groups could be transferred between amino acids and alpha-keto acids without the intermediacy of free ammonia. The PLP cofactor mechanism was elucidated in the 1960s by Esmond Snell and Alexander Braunstein, who showed that PLP forms a Schiff base with the substrate and that the conjugated ring system of PLP stabilizes the carbanion intermediate.

Arthur Kornberg and colleagues purified and characterized several of the urea cycle enzymes in the 1950s, establishing their individual properties. The mitochondrial localization of CPS1 and OTC, and the cytosolic localization of ASS, ASL, and arginase, was determined by subcellular fractionation studies in the 1960s, revealing the compartmentalization of the cycle across two cellular compartments.

The discovery of phenylketonuria by Asbjorn Folling in 1934 was a landmark in biochemical genetics. Folling identified phenylpyruvate in the urine of intellectually disabled patients and traced it to a defect in phenylalanine metabolism. Robert Guthrie developed the bacterial inhibition assay for newborn screening of PKU in 1961, establishing the principle of population-wide biochemical screening that now tests for dozens of metabolic disorders.

Horwitz and Knox identified maple syrup urine disease in 1954, describing the characteristic odor and the accumulation of branched-chain amino acids and their keto acids. The BCKDH complex was characterized in the 1970s, and its structural and mechanistic similarity to pyruvate dehydrogenase was recognized, illustrating the modular design principle of multi-enzyme dehydrogenase complexes.

The nitrogen balance concept was formalized by Carl Voit in the 1860s, who measured dietary nitrogen intake and urinary nitrogen excretion to establish the principles of protein nutrition. Graham Lusk extended this work in the early 20th century, relating nitrogen balance to energy metabolism and establishing the quantitative foundations of nutritional biochemistry.

Bibliography Master

1. Alberts, B., Hopkin, K., Johnson, A., Morgan, D., Roberts, K., & Walter, P. — Molecular Biology of the Cell, 7th ed. (Garland Science, 2022). Chapter 2: Catalysis and the Use of Energy by Cells.

2. Berg, J. M., Tymoczko, J. L., & Stryer, L. — Biochemistry, 9th ed. (W. H. Freeman, 2019). Chapter 23: Protein Turnover and Amino Acid Catabolism.

3. Berg, J. M., Tymoczko, J. L., & Stryer, L. — Biochemistry, 9th ed. (W. H. Freeman, 2019). Chapters 24–25: The Biosynthesis of Amino Acids and Nucleotide Biosynthesis.

4. Morris, S. M. — "Regulation of enzymes of the urea cycle and arginine metabolism." J. Nutr. 132 (2002): 2743S–2747S.

5. Krebs, H. A. & Henseleit, K. — "Untersuchungen uber die Harnstoffbildung im Tierkorper." Hoppe-Seyler's Z. Physiol. Chem. 210 (1932): 33–66.

6. Braunstein, A. E. & Kritzmann, M. G. — "Uber den Ab- und Aufbau von Aminosauren durch Umaminierung." Enzymologia 2 (1937): 129–146.

7. Folling, A. — "Uber Ausscheidung von Phenylbrenztraubensaure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillitat." Hoppe-Seyler's Z. Physiol. Chem. 227 (1934): 169–176.

8. Guthrie, R. & Susi, A. — "A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants." Pediatrics 32 (1963): 338–343.